{"id":45705,"date":"2022-06-30T18:01:45","date_gmt":"2022-06-30T16:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-aspiration-biopsy-needles-market-2022-to-2028-size-share-industry-trends-analysis-report-researchandmarkets-com\/"},"modified":"2022-06-30T18:01:45","modified_gmt":"2022-06-30T16:01:45","slug":"global-aspiration-biopsy-needles-market-2022-to-2028-size-share-industry-trends-analysis-report-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-aspiration-biopsy-needles-market-2022-to-2028-size-share-industry-trends-analysis-report-researchandmarkets-com\/","title":{"rendered":"Global Aspiration & Biopsy Needles Market (2022 to 2028) – Size, Share & Industry Trends Analysis Report – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Aspiration & Biopsy Needles Market Size, Share & Industry Trends Analysis Report By Product Type, By Procedure, By Image-guided Type, By End User, By Application, By Tumor\/ Cancer Applications Type, By Regional Outlook and Forecast, 2022-2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe Global Aspiration & Biopsy Needles Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.\n<\/p>\n

\nA biopsy is a surgical operation that involves removing tissue from an organ to detect the existence or degree of a disease, most commonly cancer and inflammatory disorders. Surgeons, radiologists, and interventional cardiologists are the most common practitioners. As a confirmatory test for cancer and celiac disease, biopsies can be conducted on any organ using specialized biopsy instruments. The type of organ under consideration determines how each biopsy equipment is used.\n<\/p>\n

\nAdvanced imaging technologies, such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, CT scan, and others, can be used in conjunction with traditional biopsy techniques to perform a biopsy with accuracy and least invasiveness. Biopsies of body organs such as the liver, lungs, and kidneys are performed using these integrated methods.\n<\/p>\n

\nNeedle biopsy is a method of removing a sample of cells from the body by inserting a needle into the appropriate sampling area. The tissue is then examined in a laboratory to discover if it contains any abnormalities. A needle biopsy is used to determine the cause of symptoms such as a tumor, lump, inflammation, or infection. Computed tomography or ultrasound may be utilized in conjunction with a needle biopsy to provide more precise results.\n<\/p>\n

\nTo check anomalies at a specific location, radiologists and surgeons use biopsy needle techniques such as core-needle and fine-needle procedures. Increased demand for minimally invasive procedures, as well as cancer awareness programs run by governments and worldwide health organizations, are expected to drive Market growth throughout the forecast period.\n<\/p>\n

\nMarket driving Factors:<\/strong>\n<\/p>\n

\nRising Incidences of Cancer<\/strong>\n<\/p>\n

\nThere has been a spike in the number of people diagnosed with cancer around the world. This can be due to a variety of factors, including changes in lifestyle, bad diets, and increased cigarette use. According to the International Agency for Research on Cancer (IARC), 17.0 million new cancer cases and 9.5 million cancer deaths occurred globally in 2018. The global burden of cancer is anticipated to rise to 27.5 million new cases and 16.3 million deaths by 2040, owing to population expansion and aging.\n<\/p>\n

\nRising Demand in Emerging Countries<\/strong>\n<\/p>\n

\nDisruptive business trends are expected as spanning from shifting supply chains to cost savings, automation, and a focus on customers. Companies that recognize and align their operations with industry trends will gain significant Market share. In the aspiration and biopsy needles Market, emerging Market s such as India, China, Brazil, and Mexico are expected to provide considerable growth potential for competitors. This can be ascribed to increased healthcare expenditures, improved living conditions, a broad target population base, improved and expanded healthcare infrastructure, and modernization of healthcare research and facilities in these countries.\n<\/p>\n

\nMarketing Restraining Factor:<\/strong>\n<\/p>\n

\nReusing Aspiration and Biopsy Needles Poses Risk of Infection to Patients<\/strong>\n<\/p>\n

\nRadiologists and surgeons use biopsy needle procedures such as core-needle and fine-needle procedures to examine anomalies at a specific spot. Patients may, however, get infections as a result of the cuts and incisions used to remove tissue samples. Furthermore, aspiration and biopsy needles are frequently reused, raising the infection risk during these procedures. Despite the fact that the reuse of some needles is discouraged by healthcare authorities and product manufacturers, the practice persists, particularly in developing nations.\n<\/p>\n

\nScope of the Study<\/strong>\n<\/p>\n

\nMarket Segments Covered in the Report:<\/strong>\n<\/p>\n

\nBy Product Type<\/strong>\n<\/p>\n